Pediapharm Inc. (CVE:MDP)’s share price rose 6.3% during trading on Friday . The company traded as high as C$4.20 and last traded at C$4.20, approximately 5,406 shares changed hands during mid-day trading. A decline of 16% from the average daily volume of 6,468 shares. The stock had previously closed at C$3.95.
The company has a current ratio of 1.17, a quick ratio of 0.59 and a debt-to-equity ratio of 159.84. The firm has a market capitalization of $38.66 million and a price-to-earnings ratio of -9.68. The firm has a 50 day moving average price of C$3.19 and a two-hundred day moving average price of C$3.19.
Pediapharm Company Profile (CVE:MDP)
Medexus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
See Also: Ex-Dividend
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.